1. Home
  2. PGEN vs VREX Comparison

PGEN vs VREX Comparison

Compare PGEN & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • VREX
  • Stock Information
  • Founded
  • PGEN 1998
  • VREX 2016
  • Country
  • PGEN United States
  • VREX United States
  • Employees
  • PGEN N/A
  • VREX N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • VREX Industrial Machinery/Components
  • Sector
  • PGEN Health Care
  • VREX Technology
  • Exchange
  • PGEN Nasdaq
  • VREX Nasdaq
  • Market Cap
  • PGEN 493.0M
  • VREX 483.7M
  • IPO Year
  • PGEN N/A
  • VREX N/A
  • Fundamental
  • Price
  • PGEN $4.78
  • VREX $11.89
  • Analyst Decision
  • PGEN Buy
  • VREX Strong Buy
  • Analyst Count
  • PGEN 5
  • VREX 2
  • Target Price
  • PGEN $7.67
  • VREX $19.50
  • AVG Volume (30 Days)
  • PGEN 4.5M
  • VREX 220.6K
  • Earning Date
  • PGEN 11-13-2025
  • VREX 11-18-2025
  • Dividend Yield
  • PGEN N/A
  • VREX N/A
  • EPS Growth
  • PGEN N/A
  • VREX N/A
  • EPS
  • PGEN N/A
  • VREX N/A
  • Revenue
  • PGEN $6,309,000.00
  • VREX $821,400,000.00
  • Revenue This Year
  • PGEN $249.10
  • VREX $5.01
  • Revenue Next Year
  • PGEN $710.03
  • VREX $2.97
  • P/E Ratio
  • PGEN N/A
  • VREX N/A
  • Revenue Growth
  • PGEN 59.20
  • VREX N/A
  • 52 Week Low
  • PGEN $0.65
  • VREX $6.76
  • 52 Week High
  • PGEN $5.23
  • VREX $16.93
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 68.44
  • VREX 50.16
  • Support Level
  • PGEN $3.74
  • VREX $11.54
  • Resistance Level
  • PGEN $4.04
  • VREX $12.65
  • Average True Range (ATR)
  • PGEN 0.33
  • VREX 0.51
  • MACD
  • PGEN 0.02
  • VREX -0.00
  • Stochastic Oscillator
  • PGEN 75.11
  • VREX 39.11

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Share on Social Networks: